Documents
Application Sponsors
| ANDA 077381 | DR REDDYS LABS INC | |
Marketing Status
Application Products
| 001 | TABLET, EXTENDED RELEASE;ORAL | 220MG;120MG | 0 | NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE | NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2006-09-27 | |
| LABELING; Labeling | SUPPL | 3 | AP | 2011-05-24 | |
| LABELING; Labeling | SUPPL | 6 | AP | 2015-05-04 | |
Submissions Property Types
CDER Filings
DR REDDYS LABS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 77381
[companyName] => DR REDDYS LABS INC
[docInserts] => ["",""]
[products] => [{"drugName":"NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE","activeIngredients":"NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE","strength":"220MG;120MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE","submission":"NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE","actionType":"220MG;120MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)